Share on StockTwits

T2 Biosystems (NASDAQ:TTOO) Director Thomas J. Carella bought 909,090 shares of T2 Biosystems stock in a transaction that occurred on Tuesday, August 12th. The shares were purchased at an average cost of $11.00 per share, for a total transaction of $9,999,990.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

T2 Biosystems (NASDAQ:TTOO) traded up 3.10% on Thursday, hitting $17.29. 94,303 shares of the company’s stock traded hands. T2 Biosystems has a 52-week low of $13.40 and a 52-week high of $17.24. The stock has a 50-day moving average of $14. and a 200-day moving average of $14.. The company’s market cap is $25.2 million.

T2 Biosystems, Inc is an in vitro diagnostics company. The Company that has developed a technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies.

Receive News & Ratings for T2 Biosystems Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.